Serum hepcidin following autologous hematopoietic cell transplantation: An illustration of the interplay of iron status, erythropoiesis and inflammation

Haematologica

Volumn 99, Issue 3, 2014, Pages

  Jaspers, Aurélie ^a   Baron, Frédéric ^a   Willems, Évelyne ^a   Seidel, Laurence ^b   Wiegerinck, Erwin T ^c,d   Swinkels, Dorine W ^c,d   Beguin, Yves ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NONE

Author keywords

Autologous hematopoietic cell transplantation; Darbepoetin alfa; Erythropoietin therapy; Hepcidin; Iron

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; IRON; IRON SACCHARATE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; TRANSFERRIN RECEPTOR;

ADULT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROPOIESIS; FEMALE; HUMAN; INFLAMMATION; LETTER; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TIME OF FLIGHT MASS SPECTROMETRY; AUTOTRANSPLANTATION; BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM;

ADULT; ERYTHROPOIESIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPCIDINS; HUMANS; INFLAMMATION; IRON; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 84895734897     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.100032     Document Type: Letter

References (13)

1. Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011;117(17):4425-33.
2. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002; 110(7):1037-44.
3. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin Chem. 2011; 57(12):1650-69.
4. Armand P, Kim HT, Rhodes J, Sainvil MM, Cutler C, Ho VT, et al. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(6):852-60.
5. Kanda J, Mizumoto C, Kawabata H, Tsuchida H, Tomosugi N, Matsuo K, et al. Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Haematologica. 2008; 93(10):1550-4.
6. Eisfeld AK, Westerman M, Krahl R, Leiblein S, Liebert UG, Hehme M, et al. Highly Elevated Serum Hepcidin in Patients with Acute Myeloid Leukemia prior to and after Allogeneic Hematopoietic Cell Transplantation: Does This Protect from Excessive Parenchymal Iron Loading? Adv Hematol. 2011:491058.
7. Kanda J, Mizumoto C, Kawabata H, Ichinohe T, Tsuchida H, Tomosugi N, et al. Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15(8):956-62.
8. Beguin Y, Maertens J, De Prijck B, Schots R, Seidel L, Bonnet C, et al. Darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial. Am J Hematol. 2013;88(12):990-6
9. Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, van Ede AE, et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem. 2010;56(10):1570-9.
10. Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, et al. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica. 2010;95(3):505-8.
11. van der Putten K, Jie KE, van den Broek D, Kraaijenhagen RJ, Laarakkers C, Swinkels DW, et al. Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients. Eur J Heart Fail. 2010;12(9):943-50.
12. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med. 2007;13(9):1096-101.
13. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 2006;108(12):3730-5.